NCT02018315View on ClinicalTrials.gov

Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D)

PHASE1CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

January 31, 2013

Study Completion Date

March 31, 2014

Conditions
Glucose Transporter Type 1 Deficiency SyndromeGLUT1 Deficiency Syndrome
Interventions
DRUG

Triheptanoin

Triheptanoin is a 7-carbon medium chain triglyceride

Trial Locations (1)

75390

UT Southwestern Medical Center, Dallas

All Listed Sponsors
lead

Juan Pascual

OTHER

NCT02018315 - Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D) | Biotech Hunter | Biotech Hunter